Nuvig Therapeutics appoints Dr. James Mackay to its Board of Directors as Independent Chair alongside Dr. David Woodhouse as CEO
– USA, CA – Nuvig Therapeutics, Inc., a privately held biotechnology company developing novel immunomodulatory therapeutics for patients with inflammatory autoimmune diseases, announced the appointment of Dr.…